GSK to limit payments to doctors in the US to $150 000 per year

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1663, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer care in the UK does not match the best in Europe, which is costing the UK 10 000 lives per year, the national clinical director for cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 619, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A record price of $US20 000 has been revealed by manufacturing partners Roche and Trimeris for a one-year supply of their new drug enfuvirtide [`Fuzeon']

Inpharma, Vol. 1, Iss. 1380, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A record price of $US20 000 has been revealed by manufacturing partners Roche and Trimeris for a one-year supply of their new drug enfuvirtide [`Fuzeon']

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 405, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

GSK agrees with FDA: new US labelling for Advair and Serevent

Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Guilty plea and record $3 billion fine for GSK in US

Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite